Respiree Expands Series A Syndicate with International Investors

HOUSTON and SINGAPORE, Sept. 21, 2026 /CourierPR/ -- Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, has expanded its Series A syndicate with the addition of ARKRAY & PARTNERS Pte. Ltd. (AAP) and Bizedge Capital. The company is now backed by a diverse group of investors, including We Venture Capital, ClavystBio, Adaptive Capital Partners, Greenwillow Capital Management, Seeds Capital, and One Six 8 Ventures.

Respiree’s Series A round, led by We Venture Capital and ClavystBio, has seen the company secure significant support from international investors. The expanded round will be used to continue the growth of its global commercial team and its presence in the United States, which has been expanding from Houston at the Texas Medical Center (TMC) Innovation.

Dr. Gurpreet Singh, Founder and CEO of Respiree, expressed enthusiasm about the growing interest from leading investors.

Respiree™ is an AI/ML health tech company building state-of-the-art clinically-validated AI for managing disease progression across healthcare’s care continuum. The 1Bio™ platform uses data from the EHR and its proprietary US-patented and FDA-cleared sensors to longitudinally measure and track disease progression. The company is now available in the U.S., Australia, and Asia-Pacific (APAC). Respiree™ is CE marked, has received regulatory clearances in Australia from the Therapeutics Goods Administration, and has received the 510k clearance from the United States Food and Drug Administration (FDA).

ARKRAY & PARTNERS Pte. Ltd. (AAP), an affiliate of ARKRAY, Inc. headquartered in Kyoto, Japan, was established in September 2012. It operates "ARKRAY 4U (ARKRAY FOR YOU)," a corporate venture capital (CVC) business dedicated to startups. With an investment allocation of JPY 10 billion, AAP primarily targets medical and healthcare-related startups and businesses in Japan and across Asia, including India and Israel, providing full support for the growth of innovative businesses and technologies.

Bizedge Capital is a private investment firm focused on transformative companies in semiconductors, artificial intelligence, robotics, automation, and related fields. The firm does not chase logos or consensus rounds; its edge is proprietary intelligence that surfaces category-defining companies before the broader market catches on. Bizedge Capital is led by an 18-year VC veteran with a proven record of outcomes.